106 related articles for article (PubMed ID: 640817)
21. Determination of pyridinol carbamate in plasma using high-performance liquid chromatography.
Bernard N; Brazier JL; Sassard J
J Chromatogr; 1978 May; 152(1):260-4. PubMed ID: 649748
[No Abstract] [Full Text] [Related]
22. [The effect of clofibrate (Miscleron) and pyridinol carbamate (Prodectin) on immunologic factors in experimental arteriosclerosis].
Szondy E; Horváth M; Füst G; Fehér J; Link E; Gerö S
Orv Hetil; 1979 Jun; 120(23):1391-2. PubMed ID: 492681
[No Abstract] [Full Text] [Related]
23. [Drug-induced liver injury].
Denk H
Verh Dtsch Ges Pathol; 2002; 86():120-5. PubMed ID: 12647360
[TBL] [Abstract][Full Text] [Related]
24. [Action of pyridinol carbamate on hetero-immune Masugi nephritis in the rat (author's transl)].
Lagrue G; Hirbec G; Moisy M; Sternberg M; Blanc C
Pathol Biol (Paris); 1976 Sep; 24(7):477-81. PubMed ID: 790274
[TBL] [Abstract][Full Text] [Related]
25. [Effect of pyridinol carbamate on long-term lathyrism and experimental atheroma in the rat. Histological and biochemical study].
Bouissou H; de Graeve J; Julian M; Pieraggi MT; Thiers JC
Paroi Arterielle; 1980; 6(1):3-15. PubMed ID: 7422355
[TBL] [Abstract][Full Text] [Related]
26. [Protective effect of carbamate pyridinol on experimental atheroma in the rat].
Bouissou H; Julian M; Pieraggi MT
Pathol Biol (Paris); 1974 Oct; 22(8):713-20. PubMed ID: 4614172
[No Abstract] [Full Text] [Related]
27. [Pyridinolcarbamate (anginin) in the treatment of diabetic angiopathies].
Tirkina TN; Aleksandrova LM; Kliachko VR; Mazovetskiĭ AG
Ter Arkh; 1974; 46(1):107-10. PubMed ID: 4453966
[No Abstract] [Full Text] [Related]
28. Chronic lathyrism and pyridinol carbamate. Study of aorta and plasma during long term intoxication.
Julian M; De Graeve J; Pieraggi MT; Thiers JC; Bouissou H
Pharmacol Res Commun; 1980 Oct; 12(9):847-54. PubMed ID: 7443765
[No Abstract] [Full Text] [Related]
29. [Psychophysiological aspect of the therapeutic use of pyridinolcarbamate].
Sidorenko GI; Borisova GS; Sidorenko ER; Polonetskii LZ; Gelis LG
Kardiologiia; 1983 Mar; 23(3):66-71. PubMed ID: 6855067
[TBL] [Abstract][Full Text] [Related]
30. [The effect of ximedon on cholesterol metabolism and experimental atherosclerosis in rabbits].
Dautova GS; Kosykh VA; Repin VS; Kamburg RA; Ibragimov OB; Popova LG; Valeeva IKh
Eksp Klin Farmakol; 1995; 58(1):25-9. PubMed ID: 7787689
[TBL] [Abstract][Full Text] [Related]
31. [Use of clofibrate and pyridinol carbamate singly or in combination in the antiarteriosclerotic therapy].
Meciani L; Boeri S; Ricci G
Minerva Cardioangiol; 1974; 22(7-8):512-42. PubMed ID: 4606052
[No Abstract] [Full Text] [Related]
32. Hepatotoxicity of methotrexate in the treatment of psoriasis.
Palmer HM
Practitioner; 1973 Sep; 211(263):324-8. PubMed ID: 4759241
[No Abstract] [Full Text] [Related]
33. Hepatic toxicity from large doses of vitamin B3 (nicotinamide).
Winter SL; Boyer JL
N Engl J Med; 1973 Nov; 289(22):1180-2. PubMed ID: 4271091
[No Abstract] [Full Text] [Related]
34. Hepatic scintiscanning in fulminant hepatic failure.
Murray-Lyon IM; Davidson AR; Rake MO; Osborn SB; Williams R
Br J Radiol; 1973 Jan; 46(541):30-3. PubMed ID: 4683327
[No Abstract] [Full Text] [Related]
35. Pharmacokinetic study of pyridinol carbamate in chronic renal insufficiency.
Mallein R; François B; Rondelet J; Ksavrelof H
Eur J Drug Metab Pharmacokinet; 1984; 9(2):141-8. PubMed ID: 6745304
[TBL] [Abstract][Full Text] [Related]
36. Hepatic granulomas: review of 73 patients from one hospital and survey of the literature.
Irani SK; Dobbins WO
J Clin Gastroenterol; 1979 Jun; 1(2):131-43. PubMed ID: 400661
[No Abstract] [Full Text] [Related]
37. On the mechanism of antiatherosclerotic agents: microchemical studies on the in vitro effects of pyridinol carbamate and estrogen (premarin) on phosphofructokinase and malate dehydrogenase in the arterial wall.
Numano F; Yamasawa S; Takano T; Shimamoto T
Mech Ageing Dev; 1973; 2(1):43-53. PubMed ID: 4352474
[No Abstract] [Full Text] [Related]
38. Changes in liver disturbance associated with long-term tranquilizing medication. (A follow-up study).
Bloom JB; Davis N
Dis Nerv Syst; 1970 May; 31(5):309-17. PubMed ID: 5426956
[No Abstract] [Full Text] [Related]
39. Hepatic injury due to oxacillin administration.
Goldstein LI; Granoff M; Waisman J
Am J Gastroenterol; 1978 Aug; 70(2):171-4. PubMed ID: 717369
[TBL] [Abstract][Full Text] [Related]
40. Studies on the protective effectiveness of drugs against the hepatic toxicity of primaquine diphosphate in rabbits.
el-Denshary ES; Scott PM; el-Masri AM
J Egypt Med Assoc; 1969; 52(7):552-60. PubMed ID: 5365917
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
